The research team is now monitoring 12 more participants who received higher doses of 150,000 and 250,000 cells. If no safety ...
In a study published in Cell Stem Cell, scientists tested retinal pigment epithelial stem cells in a phase 1/2a clinical trial. The cells were obtained from adult postmortem eye tissue. These ...
Scientists have discovered why males get dental disease more frequently and with greater severity than females, pinpointing ...
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) sells medicines for eye conditions, immune disorders, cancer, cardiovascular issues, infections, and rare diseases.
Following the federal government's changes to COVID-19 vaccine eligibility and recommendations in 2025, many people are ...
Beyond relieving pressure on existing NHS services, home testing could offer patients greater choice, more convenience, ...
A key protein, LRG1, was identified as the early cause of diabetic eye damage, and blocking it may stop the disease before ...
In this video from the American Academy of Ophthalmology meeting, Lejla Vajzovic, MD, FASRS, highlights a presentation on macular telangiectasia type 2.